EpiVax's Grant - XIV Round

EpiVax raised a round of funding on September 16, 2008. Investors include The Montel Williams MS Foundation.

EpiVax, is a privately held biotechnology company focused on the development of vaccines and immunotherapies for infectious diseases, autoimmunity and cancer. The immunoinformatics team at EpiVax has …

Articles about EpiVax's Grant - XIV Round: